Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Becatecarin in Advanced Renal Cell Cancer
NCT00005027Phase 2Completed
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Start
- Jun 2000
- Primary completion
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of becatecarin in renal cell carcinoma (RCC), sponsored by Barbara Ann Karmanos Cancer Institute. Primary endpoints: Response Rate and Toxicities. Started Jun 2000; status: completed.
02
Drugs
becatecarin
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00005027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005027.